Healthpeak Properties (PEAK) Stock Price, News & Analysis

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Healthpeak Properties in the last year. There are currently 2 sell ratings, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PEAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PEAK, but not buy additional shares or sell existing shares.
View PEAK analyst ratings or view top-rated stocks.

10 Wall Street analysts have issued 12 month price targets for Healthpeak Properties' shares. Their PEAK share price targets range from $17.50 to $32.00. On average, they expect the company's stock price to reach $23.05 in the next year. This suggests a possible upside of 32.9% from the stock's current price.
View analysts price targets for PEAK or view top-rated stocks among Wall Street analysts.

Healthpeak Properties' stock was trading at $19.80 at the beginning of 2024. Since then, PEAK stock has decreased by 12.4% and is now trading at $17.34.
View the best growth stocks for 2024 here.

Healthpeak Properties saw a increase in short interest in January. As of January 15th, there was short interest totaling 9,760,000 shares, an increase of 14.8% from the December 31st total of 8,500,000 shares. Based on an average daily volume of 5,740,000 shares, the short-interest ratio is presently 1.7 days. Approximately 1.8% of the company's stock are sold short.
View Healthpeak Properties' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our PEAK earnings forecast.

Healthpeak Properties, Inc. (NYSE:PEAK) announced its earnings results on Thursday, February, 8th. The company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.45 by $0.32. The business had revenue of $553.65 million for the quarter, compared to the consensus estimate of $553.77 million. Healthpeak Properties had a net margin of 13.97% and a trailing twelve-month return on equity of 4.34%. Healthpeak Properties's revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.44 earnings per share.

Healthpeak Properties announced a quarterly dividend on Wednesday, January 31st. Shareholders of record on Wednesday, February 14th will be given a dividend of $0.30 per share on Monday, February 26th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.92%. The ex-dividend date is Tuesday, February 13th.
Read our dividend analysis for PEAK.

Healthpeak Properties (NYSE:PEAK) pays an annual dividend of $1.20 per share and currently has a dividend yield of 6.92%. PEAK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 214.29%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PEAK will have a dividend payout ratio of 63.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PEAK.

ETFs with the largest weight of Healthpeak Properties (NYSE:PEAK) stock in their portfolio include Janus Henderson U.S. Real Estate ETF (JRE), iShares Residential and Multisector Real Estate ETF (REZ), Invesco S&P 500 Equal Weight Real Estate ETF (RSPR), Invesco S&P 500 Equal Weight Real Estate ETF (EWRE), Invesco Real Assets ESG ETF (IVRA), WisdomTree New Economy Real Estate Fund (WTRE), ETFB Green SRI REITs ETF (RITA) and ALPS Active REIT ETF (REIT).

Healthpeak Properties issued an update on its FY 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of 1.730-1.790 for the period, compared to the consensus earnings per share estimate of 1.810. The company issued revenue guidance of -.

10 employees have rated Healthpeak Properties Chief Executive Officer Thomas M. Herzog on Glassdoor.com. Thomas M. Herzog has an approval rating of 100% among the company's employees. This puts Thomas M. Herzog in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Healthpeak Properties' stock is owned by many different institutional and retail investors. Top institutional investors include Norges Bank (1.52%), Dimensional Fund Advisors LP (1.48%), Charles Schwab Investment Management Inc. (1.38%), Sumitomo Mitsui Trust Holdings Inc. (0.76%), Nuance Investments LLC (0.65%) and Swiss National Bank (0.31%). Insiders that own company stock include Christine Garvey, Sara Grootwassink Lewis, Scott M Brinker and Thomas Klaritch.
View institutional ownership trends.

Shares of PEAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.